Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × FED × Urinary Bladder Neoplasms × Clear all

Phase

Phase NA 3 Phase 1/2 1

Status

Sponsor Class

INDUSTRY 53 OTHER 43 NIH 3 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 2 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Small Cell Lung Carcinoma 1 Ovarian Neoplasms 1 Neoplasms 1 Lung Neoplasms 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Hepatocellular 1

Interventions

copanlisib 1 avelumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05687721 2025-06-15

Copanlisib and Avelumab as a Maintenance Therapy for Advanced Bladder Cancer

VA Office of Research and Development

Phase 1/2 Withdrawn

Urinary Bladder Neoplasms, Ureteral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡